Jefferies Group's COLL Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 24,300 shares of Collegium Pharmaceutical, Inc. (COLL) worth $803,601, representing 0.01% of the portfolio. First purchased in 2017-Q1, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in COLL, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 311,292 shares. Largest reduction occurred in Q3 2024, reducing 302,000 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Collegium Pharmaceutical (COLL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Collegium Pharmaceutical (COLL) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -19,940 | Reduce 45.07% | 24,300 | $33.07 |
| Q4 2025 | -82,325 | Reduce 65.05% | 44,240 | $46.30 |
| Q3 2025 | +126,565 | New Buy | 126,565 | $34.99 |
| Q4 2024 | -50,000 | Sold Out | 0 | $0.00 |
| Q3 2024 | -302,000 | Reduce 85.80% | 50,000 | $38.64 |
| Q2 2024 | +311,292 | Add 764.69% | 352,000 | $32.20 |
| Q1 2024 | +40,708 | New Buy | 40,708 | $38.82 |
| Q1 2023 | -28,750 | Sold Out | 0 | $0.00 |
| Q4 2022 | +28,750 | New Buy | 28,750 | $23.20 |
| Q2 2017 | -83,759 | Sold Out | 0 | $0.00 |
| Q1 2017 | +83,759 | New Buy | 83,759 | $10.06 |
Jefferies Group's Collegium Pharmaceutical Investment FAQs
Jefferies Group first purchased Collegium Pharmaceutical, Inc. (COLL) in Q1 2017, acquiring 83,759 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Collegium Pharmaceutical, Inc. (COLL) for 11 quarters since Q1 2017.
Jefferies Group's largest addition to Collegium Pharmaceutical, Inc. (COLL) was in Q2 2024, adding 352,000 shares worth $11.33 M.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 24,300 shares of Collegium Pharmaceutical, Inc. (COLL), valued at approximately $803,601.
As of the Q1 2026 filing, Collegium Pharmaceutical, Inc. (COLL) represents approximately 0.01% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Collegium Pharmaceutical, Inc. (COLL) was 352,000 shares, as reported at the end of Q2 2024.